Clinical trials
Phase 2 Lupus Erythematosus, Systemic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 8 |
| Active, not recruiting | 5 |
| Not yet recruiting | 4 |
| Terminated | 4 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 4 |
| AbbVie | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Novartis Pharmaceuticals | 2 |
| Beeline Medicines Corporation | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Beijing Mabworks Biotech Co., Ltd. | 1 |
| Boehringer Ingelheim | 1 |
| Chinese University of Hong Kong | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 32 |
| Lupus Nephritis | 3 |
| Lupus Erythematosus, Cutaneous | 2 |
| Lupus Erythematosus, Discoid | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Antiphospholipid Syndrome | 1 |
| Autoimmune Diseases | 1 |
| Behcet Syndrome | 1 |
| Connective Tissue Diseases | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.